Patent Disputes Do Not Pay Off, Merck Says: Sweet Spot In “Bitter Medicine”

Aggressive patent defensive strategies do not pay off on Wall Street, Merck CEO Ray Gilmartin told Peter Jennings during an ABC News special, "Bitter Medicine: Pills, Profit and the Public Health," which aired May 29